Year |
Citation |
Score |
2024 |
Sanchez A, Ortega P, Sakhtemani R, Manjunath L, Oh S, Bournique E, Becker A, Kim K, Durfee C, Temiz NA, Chen XS, Harris RS, Lawrence MS, Buisson R. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes. Nature Communications. 15: 2370. PMID 38499542 DOI: 10.1038/s41467-024-45909-5 |
0.322 |
|
2023 |
Carpenter MA, Temiz NA, Ibrahim MA, Jarvis MC, Brown MR, Argyris PP, Brown WL, Starrett GJ, Yee D, Harris RS. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer. Plos Genetics. 19: e1011043. PMID 38033156 DOI: 10.1371/journal.pgen.1011043 |
0.344 |
|
2023 |
Durfee C, Temiz NA, Levin-Klein R, Argyris PP, Alsøe L, Carracedo S, Alonso de la Vega A, Proehl J, Holzhauer AM, Seeman ZJ, Liu X, Lin YT, Vogel RI, Sotillo R, Nilsen H, et al. Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases. Cell Reports. Medicine. 4: 101211. PMID 37797615 DOI: 10.1016/j.xcrm.2023.101211 |
0.311 |
|
2023 |
Sanchez A, Ortega P, Sakhtemani R, Manjunath L, Oh S, Bournique E, Becker A, Kim K, Durfee C, Temiz NA, Chen XS, Harris RS, Lawrence MS, Buisson R. Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes. Biorxiv : the Preprint Server For Biology. PMID 37577509 DOI: 10.1101/2023.08.02.551499 |
0.322 |
|
2023 |
Naumann JA, Argyris PP, Carpenter MA, Gupta HB, Chen Y, Temiz NA, Zhou Y, Durfee C, Proehl J, Koniar BL, Conticello SG, Largaespada DA, Brown WL, Aihara H, Vogel RI, et al. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo. International Journal of Molecular Sciences. 24. PMID 37298259 DOI: 10.3390/ijms24119305 |
0.312 |
|
2020 |
Law EK, Levin-Klein R, Jarvis MC, Kim H, Argyris PP, Carpenter MA, Starrett GJ, Temiz NA, Larson LK, Durfee C, Burns MB, Vogel RI, Stavrou S, Aguilera AN, Wagner S, et al. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. The Journal of Experimental Medicine. 217. PMID 32870257 DOI: 10.1084/Jem.20200261 |
0.413 |
|
2018 |
Jarvis MC, Ebrahimi D, Temiz NA, Harris RS. Mutation Signatures Including APOBEC in Cancer Cell Lines. Jnci Cancer Spectrum. 2. PMID 29888758 DOI: 10.1093/Jncics/Pky002 |
0.43 |
|
2018 |
Truong TH, Hu H, Temiz NA, Hagen K, Girard BJ, Brady NJ, Schwertfeger KL, Lange CA, Ostrander JH. Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models are Promoted by PELP1/AIB1 Complexes. Molecular Cancer Research : McR. PMID 29348189 DOI: 10.1158/1541-7786.Mcr-17-0598 |
0.386 |
|
2018 |
Scott M, Temiz N, Sarver A, LaRue R, Rathe S, Varshney J, Wolf N, Moriarity B, Obrien T, Spector L, Largaespada D, Modiano J, Subramanian S, Sarver A. Abstract PR14: Immune cell transcript levels, metastatic progression, and survival in osteosarcoma: A comparative transcriptome analysis Omics a Journal of Integrative Biology. 24. DOI: 10.1158/1557-3265.Sarcomas17-Pr14 |
0.34 |
|
2018 |
Sarver AL, Mills L, Temiz N, Scott M, Sarver A, Spector L, Wang J, Breen M, Subramanian S, Moriarity B, Modiano J, Largaespada D. Abstract 3399: Comparative genomic analyses of osteosarcoma etiology reveal a chromosomal structural rationale for the increased incidence of osteosarcoma in dogs Cancer Research. 78: 3399-3399. DOI: 10.1158/1538-7445.Am2018-3399 |
0.359 |
|
2018 |
Camilleri ET, Beckmann PJ, Larson JD, Kurata M, Shu J, Pope E, Hudson WA, Temiz NA, Rathe SK, LaRue RS, Sarver AE, Scott MC, Varshney J, Modiano JF, Moriarity BS, et al. Abstract 2264: RNA sequencing based analysis of transposon-induced tumors reveals novel insights into cancer pathogenesis and progression Cancer Research. 78: 2264-2264. DOI: 10.1158/1538-7445.Am2018-2264 |
0.395 |
|
2017 |
Scott MC, Temiz NA, Sarver AE, LaRue RS, Rathe SK, Varshney J, Wolf NK, Moriarity BS, O'Brien TD, Spector LG, Largaespada DA, Modiano JF, Subramanian S, Sarver AL. Comparative transcriptome analysis quantifies immune cell transcript levels, metastatic progression and survival in osteosarcoma. Cancer Research. PMID 29066513 DOI: 10.1158/0008-5472.Can-17-0576 |
0.337 |
|
2016 |
Law EK, Sieuwerts AM, LaPara K, Leonard B, Starrett GJ, Molan AM, Temiz NA, Vogel RI, Meijer-van Gelder ME, Sweep FC, Span PN, Foekens JA, Martens JW, Yee D, Harris RS. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Science Advances. 2: e1601737. PMID 27730215 DOI: 10.1126/Sciadv.1601737 |
0.393 |
|
2016 |
Starrett GJ, Luengas EM, McCann JL, Ebrahimi D, Temiz NA, Love RP, Feng Y, Adolph MB, Chelico L, Law EK, Carpenter MA, Harris RS. The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis. Nature Communications. 7: 12918. PMID 27650891 DOI: 10.1038/Ncomms12918 |
0.441 |
|
2016 |
Akre MK, Starrett GJ, Quist JS, Temiz NA, Carpenter MA, Tutt AN, Grigoriadis A, Harris RS. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B. Plos One. 11: e0155391. PMID 27163364 DOI: 10.1371/Journal.Pone.0155391 |
0.412 |
|
2016 |
Sarver AL, Murray CD, Temiz NA, Tseng YY, Bagchi A. MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer. Cell Cycle (Georgetown, Tex.). 0. PMID 26889781 DOI: 10.1080/15384101.2016.1149660 |
0.395 |
|
2016 |
Harris R, Law E, Sieuwerts A, LaPara K, Leonard B, Starrett G, Temiz N, Sweep F, Span P, Foekens J, Martens J, Yee D. Abstract S4-07: Tamoxifen resistance driven by the DNA cytosine deaminase APOBEC3B in recurrent estrogen receptor positive breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-S4-07 |
0.375 |
|
2015 |
Temiz NA, Moriarity BS, Wolf NK, Riordan JD, Dupuy AJ, Largaespada DA, Sarver AL. RNA sequencing of Sleeping Beauty transposon-induced tumors detect transposon-RNA fusions allowing precision analyses of forward genetic cancer screens. Genome Research. PMID 26553456 DOI: 10.1101/Gr.188649.114 |
0.317 |
|
2015 |
Temiz NA, Donohue DE, Bacolla A, Vasquez KM, Cooper DN, Mudunuri U, Ivanic J, Cer RZ, Yi M, Stephens RM, Collins JR, Luke BT. Erratum to: The somatic autosomal mutation matrix in cancer genomes. Human Genetics. 134: 865-7. PMID 26071096 DOI: 10.1007/S00439-015-1576-Z |
0.336 |
|
2015 |
Temiz NA, Donohue DE, Bacolla A, Vasquez KM, Cooper DN, Mudunuri U, Ivanic J, Cer RZ, Yi M, Stephens RM, Collins JR, Luke BT. The somatic autosomal mutation matrix in cancer genomes. Human Genetics. 134: 851-64. PMID 26001532 DOI: 10.1007/S00439-015-1566-1 |
0.407 |
|
2015 |
Moriarity BS, Otto GM, Rahrmann EP, Rathe SK, Wolf NK, Weg MT, Manlove LA, LaRue RS, Temiz NA, Molyneux SD, Choi K, Holly KJ, Sarver AL, Scott MC, Forster CL, et al. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. Nature Genetics. 47: 615-24. PMID 25961939 DOI: 10.1038/Ng.3293 |
0.303 |
|
2014 |
Vieira VC, Leonard B, White EA, Starrett GJ, Temiz NA, Lorenz LD, Lee D, Soares MA, Lambert PF, Howley PM, Harris RS. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B. Mbio. 5. PMID 25538195 DOI: 10.1128/Mbio.02234-14 |
0.332 |
|
2013 |
Leonard B, Hart SN, Burns MB, Carpenter MA, Temiz NA, Rathore A, Vogel RI, Nikas JB, Law EK, Brown WL, Li Y, Zhang Y, Maurer MJ, Oberg AL, Cunningham JM, et al. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Research. 73: 7222-31. PMID 24154874 DOI: 10.1158/0008-5472.Can-13-1753 |
0.392 |
|
2013 |
Bacolla A, Temiz NA, Yi M, Ivanic J, Cer RZ, Donohue DE, Ball EV, Mudunuri US, Wang G, Jain A, Volfovsky N, Luke BT, Stephens RM, Cooper DN, Collins JR, et al. Guanine holes are prominent targets for mutation in cancer and inherited disease. Plos Genetics. 9: e1003816. PMID 24086153 DOI: 10.1371/Journal.Pgen.1003816 |
0.426 |
|
2013 |
Burns MB, Temiz NA, Harris RS. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nature Genetics. 45: 977-83. PMID 23852168 DOI: 10.1038/Ng.2701 |
0.421 |
|
2013 |
Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 494: 366-70. PMID 23389445 DOI: 10.1038/Nature11881 |
0.436 |
|
2013 |
Conboy CB, Tschida BR, Hu H, Burns MB, Temiz NA, Kuka T, Keng VW, Toffanin S, Harris RS, Llovet J, Starr TK, Largaespada DA. Abstract A242: R-spondin 2 drives Wnt signaling and tumor formation in breast and liver cancer. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A242 |
0.371 |
|
2013 |
Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, et al. Correction: Corrigendum: APOBEC3B is an enzymatic source of mutation in breast cancer Nature. 502: 580-580. DOI: 10.1038/Nature12667 |
0.384 |
|
2012 |
Temiz NA, Donohue DE, Bacolla A, Luke BT, Collins JR. The role of methylation in the intrinsic dynamics of B- and Z-DNA. Plos One. 7: e35558. PMID 22530050 DOI: 10.1371/Journal.Pone.0035558 |
0.322 |
|
2012 |
Cer RZ, Bruce KH, Donohue DE, Temiz NA, Mudunuri US, Yi M, Volfovsky N, Bacolla A, Luke BT, Collins JR, Stephens RM. Searching for non-B DNA-forming motifs using nBMST (non-B DNA motif search tool). Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 18.7.1-22. PMID 22470144 DOI: 10.1002/0471142905.Hg1807S73 |
0.33 |
|
2010 |
Bueno M, Temiz NA, Camacho CJ. Novel modulation factor quantifies the role of water molecules in protein interactions. Proteins. 78: 3226-34. PMID 20665475 DOI: 10.1002/Prot.22805 |
0.496 |
|
2010 |
Temiz NA, Trapp A, Prokopyev OA, Camacho CJ. Optimization of minimum set of protein-DNA interactions: a quasi exact solution with minimum over-fitting. Bioinformatics (Oxford, England). 26: 319-25. PMID 19965883 DOI: 10.1093/Bioinformatics/Btp664 |
0.51 |
|
2009 |
Temiz NA, Camacho CJ. Experimentally based contact energies decode interactions responsible for protein-DNA affinity and the role of molecular waters at the binding interface. Nucleic Acids Research. 37: 4076-88. PMID 19429892 DOI: 10.1093/Nar/Gkp289 |
0.528 |
|
Show low-probability matches. |